Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 12, 2010, Pages 1561-1565

  Diacon, A H ^a   Maritz, J S ^a   Venter, A ^a   Van Helden, P D ^a   Andries, K ^b   McNeeley, D F ^c   Donald, P R ^d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b TIBOTEC BVBA   (Belgium)

^c Tibotec Inc   (United States)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL; ISONIAZID; RIFAMPICIN;

ADULT; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM DETECTION; BACTERIUM EXAMINATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CULTURE; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPUTUM CULTURE; TIME TO DETECTION; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; COLONY COUNT, MICROBIAL; CULTURE MEDIA; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; QUINOLINES; RIFAMPIN; SPUTUM; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 78651298871     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-1043-7     Document Type: Article

References (21)

1. Mitchison DA, Sturm WA (1997) The measurement of early bactericidal activity. In: Malin A, McAdam K (eds) Bailliere's Clinical Infectious Diseases: Mycobacterial Diseases Part II. Bailliere Tindall, London, pp 185-206
2. Global Alliance for TB Drug Development 2001 Tuberculosis. Scientific blueprint for tuberculosis drug development Tuberculosis (Edinb) 81 Suppl 1 1 52
3. PR Donald FA Sirgel A Venter DP Parkin HI Seifart BW van de Wal JS Maritz PB Fourie 2003 Early bactericidal activity of antituberculosis agents Expert Rev Anti Infect Ther 1 141 155 1:CAS:528:DC%2BD3sXlsFaisrY%3D 10.1586/14787210.1.1.141 15482107
4. PR Donald AH Diacon 2008 The early bactericidal activity of anti-tuberculosis drugs: a literature review Tuberculosis (Edinb) 88 Suppl 1 S75 S83 1:CAS:528:DC%2BD1cXht1CmtL7I 10.1016/S1472-9792(08)70038-6
5. A Jindani VR Aber EA Edwards DA Mitchison 1980 The early bactericidal activity of drugs in patients with pulmonary tuberculosis Am Rev Respir Dis 121 939 949 1:STN:280:DyaL3M%2FhvFygtw%3D%3D 6774638
6. A Somoskövi P Magyar 1999 Comparison of the mycobacteria growth indicator tube with MB redox, Löwenstein-Jensen, and Middlebrook 7H11 media for recovery of mycobacteria in clinical specimens J Clin Microbiol 37 1366 1369 10203488
7. GE Pfyffer HM Welscher P Kissling C Cieslak MJ Casal J Gutierrez S Rüsch-Gerdes 1997 Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli J Clin Microbiol 35 364 368 1:STN:280:DyaK2s7lsleisA%3D%3D 9003597
8. BA Hanna A Ebrahimzadeh LB Elliott MA Morgan SM Novak S Rüsch-Gerdes M Acio DF Dunbar TM Holmes CH Rexer C Savthyakumar AM Vannier 1999 Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria J Clin Microbiol 37 748 752 1:STN:280:DyaK1M7ktlansA%3D%3D 9986844
9. MD Epstein NW Schluger AL Davidow S Bonk WN Rom B Hanna 1998 Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis Chest 113 379 386 1:STN:280:DyaK1c7ktVOqtA%3D%3D 10.1378/chest.113.2.379 9498955
10. NM Carroll P Uys A Hesseling K Lawrence C Pheiffer F Salker K Duncan N Beyers PD van Helden 2008 Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures Tuberculosis (Edinb) 88 624 630 1:STN:280:DC%2BD1cjgs1ymtA%3D%3D 10.1016/j.tube.2008.03.003
11. C Pheiffer NM Carroll N Beyers P Donald K Duncan P Uys P van Helden 2008 Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting Int J Tuberc Lung Dis 12 792 798 1:STN:280:DC%2BD1cvps1ensA%3D%3D 18544206
12. K Andries P Verhasselt J Guillemont HW Göhlmann JM Neefs H Winkler J Van Gestel P Timmerman M Zhu E Lee P Williams D de Chaffoy E Huitric S Hoffner E Cambau C Truffot-Pernot N Lounis V Jarlier 2005 A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis Science 307 223 227 1:CAS:528:DC%2BD2MXisVKkug%3D%3D 10.1126/science.1106753 15591164 (Pubitemid 40116230)
13. A Matteelli AC Carvalho KE Dooley A Kritski 2010 TMC207: the first compound of a new class of potent anti-tuberculosis drugs Future Microbiol 5 849 858 1:CAS:528:DC%2BC3cXmvFeju70%3D 10.2217/fmb.10.50 20521931
14. R Rustomjee AH Diacon J Allen A Venter C Reddy RF Patientia TC Mthiyane T De Marez R van Heeswijk R Kerstens A Koul K De Beule PR Donald DF McNeeley 2008 Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis Antimicrob Agents Chemother 52 2831 2835 1:CAS:528:DC%2BD1cXps1OgtL0%3D 10.1128/AAC.01204-07 18505852
15. N Lounis T Gevers J Van Den Berg T Verhaeghe R van Heeswijk K Andries 2008 Prevention of drug carryover effects in studies assessing antimycobacterial efficacy of TMC207 J Clin Microbiol 46 2212 2215 1:CAS:528:DC%2BD1cXps1Onu7o%3D 10.1128/JCM.00177-08 18480227
16. DA Mitchison AR Coates 2004 Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugs Curr Pharm Des 10 3285 3295 1:CAS:528:DC%2BD2cXnvFart7s%3D 10.2174/1381612043383269 15544516 (Pubitemid 39276616)
17. J Dhillon DB Lowrie DA Mitchison 2004 Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium BMC Infect Dis 4 51 10.1186/1471-2334-4-51 15548322 (Pubitemid 39637286)
18. RL Peres EL Maciel CG Morais FC Ribeiro SA Vinhas C Pinheiro R Dietze JL Johnson K Eisenach M Palaci 2009 Comparison of two concentrations of NALC-NaOH for decontamination of sputum for mycobacterial culture Int J Tuberc Lung Dis 13 1572 1575 1:STN:280:DC%2BD1MjmslyisA%3D%3D 19919781
19. AH Diacon A Pym M Grobusch R Patientia R Rustomjee L Page-Shipp C Pistorius R Krause M Bogoshi G Churchyard A Venter J Allen JC Palomino T De Marez RP van Heeswijk N Lounis P Meyvisch J Verbeeck W Parys K de Beule K Andries DF McNeeley 2009 The diarylquinoline TMC207 for multidrug-resistant tuberculosis N Engl J Med 360 2397 2405 1:CAS:528:DC%2BD1MXntVKqsrs%3D 10.1056/NEJMoa0808427 19494215
20. L Li CS Mahan M Palaci L Horter L Loeffelholz JL Johnson R Dietze SM Debanne ML Joloba A Okwera WH Boom KD Eisenach 2010 Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy J Clin Microbiol 48 46 51 1:CAS:528: DC%2BC3cXhvFKqtLk%3D 10.1128/JCM.01526-09 19923475
21. RS Wallis TM Doherty P Onyebujoh M Vahedi H Laang O Olesen S Parida A Zumla 2009 Biomarkers for tuberculosis disease activity, cure, and relapse Lancet Infect Dis 9 162 172 1:CAS:528:DC%2BD1MXjs12qs78%3D 10.1016/S1473- 3099(09)70042-8 19246020